(Q38051189)

27 August 2017

title

Splicing factor mutations in myelodysplasia (English)

1 reference

27 August 2017

Seishi Ogawa

1

1 reference

27 August 2017

publication date

5 October 2012

1 reference

International Journal of Hematology

27 August 2017

published in

1 reference

27 August 2017

volume

96

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

438-442

1 reference

Myelodysplastic syndromes: the complexity of stem-cell diseases

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Unraveling the molecular pathophysiology of myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

The role of mutations in epigenetic regulators in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

A common genetic mechanism in malignant bone marrow diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Mutation in TET2 in myeloid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

DNMT3A Mutations in Acute Myeloid Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Recurring mutations found by sequencing an acute myeloid leukemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Acquired mutations in TET2 are common in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Clinical effect of point mutations in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Molecular genetics in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Frequent pathway mutations of splicing machinery in myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic/myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Novel splicing-factor mutations in juvenile myelomonocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

The spliceosome: design principles of a dynamic RNP machine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Spliceosome and other novel mutations in chronic lymphocytic leukemia and myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Mammalian polycomb-mediated repression of Hox genes requires the essential spliceosomal protein Sf3b1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Role of the INK4a locus in tumor suppression and cell mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Splicing factor SF3b as a target of the antitumor natural product pladienolide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

The development and application of small molecule modulators of SF3b as therapeutic agents for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1182-Y

SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications

21 January 2018

1 reference

12 December 2020

SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients

1 reference

12 December 2020

Whole-genome analysis informs breast cancer response to aromatase inhibition

1 reference

12 December 2020

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution

1 reference

12 December 2020

Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches

1 reference

12 December 2020

SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts

1 reference

12 December 2020

Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML

1 reference

12 December 2020

10.1007/S12185-012-1182-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1041398517

0 references

1 reference